Advertisement
In a study published in the Nov. 1 issue of The American Journal of Cardiology

Women Have Worse Outcomes During 36 Months After ACS

0
Higher incidence of composite end point for women during 36 months after acute coronary syndrome
Thirteen cases of Candida auris

CDC: 13 Cases of Candida auris Identified in the United States

0
CDC officials say drug-resistant fungal infection tied to four deaths, can be easily misidentified
Tobacco smoking causes mutations that lead to cancer by multiple distinct mechanisms

Smoking Ups Cancer Risk by Causing Distinct Cell Mutations

0
For every year of smoking a pack daily, 150 more mutations found in each lung cell
For screened men enrolled in prostate cancer prevention trials

Differences in Risk Factor Estimates for Prostate Cancer

0
Across cohorts of men undergoing screening, considerable variation in risk factor estimates
In obese canines

Bilateral Renal Denervation Normalizes Insulin Sensitivity

0
Normalization seen in obese canines, by reducing hepatic gluconeogenic genes, including G6Pase
Three injections of a therapeutic vaccine may control herpes simplex virus 2 as effectively as daily pills for at least a year

ISDA: Vaccine Might Help Prevent HSV-2 Transmission

0
Three-dose regimen seems as effective as daily pills, but more research needed

Infectious Diseases Society of America, Oct. 26-30

0
The Infectious Diseases Society of America Annual Meeting (IDWeek 2016) The annual meeting of the Infectious Diseases Society of America was held from...
A distinctive phenotype of congenital Zika syndrome has been described in a review published online Nov. 3 in JAMA Pediatrics.

Review Identifies Features of Congenital Zika Infection

0
Five factors identified as unique to Zika, including severe microcephaly with partially collapsed skull
Psoriasis patients have increased global arterial inflammation and subcutaneous inflammation

Increased Global, Subcutaneous Inflammation in Psoriasis

0
Increased 18F-fluorodeoxyglucose uptake values indicate arterial and subcutaneous inflammation
Patients with melanoma treated with a combination of ipilimumab and nivolumab may be at risk for a potentially fatal T-cell-driven drug reaction

Myocarditis ID’d With Ipilimumab + Nivolumab in Melanoma

0
Case report describes two patients who developed fatal T-cell-driven drug reaction